Literature DB >> 865621

Postsynaptic receptors are not essential for dopaminergic feedback regulation.

G Di Chiara, M L Porceddu, W Fratta, G L Gessa.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 865621     DOI: 10.1038/267270a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  Memory re-consolidation and drug conditioning: an apomorphine conditioned locomotor stimulant response can be enhanced or reversed by a single high versus low apomorphine post-trial treatment.

Authors:  Marinete Pinheiro Carrera; Robert J Carey; Flávia Regina Cruz Dias; Liana Wermelinger de Mattos
Journal:  Psychopharmacology (Berl)       Date:  2011-09-16       Impact factor: 4.530

2.  Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine.

Authors:  Flávia Regina Cruz Dias; Liana Wermelinger de Matos; Maria de Fátima Dos Santos Sampaio; Robert J Carey; Marinete Pinheiro Carrera
Journal:  Psychopharmacology (Berl)       Date:  2012-07-24       Impact factor: 4.530

3.  Some observations on the behavioural responses to metoclopramide in the pig and the guinea pig [proceedings].

Authors:  N Ely; I R Rumble; D F Sharman
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

4.  A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.

Authors:  M G Feenstra; C Sumners; J H Goedemoed; J B de Vries; H Rollema; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

5.  Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action.

Authors:  W Timmerman; J B De Vries; B H Westerink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

6.  Evidence for selective and long-lasting stimulation of "regulatory" dopamine-receptors by bromocriptine (CB 154).

Authors:  G di Chiara; M L Porceddu; L Vargiu; E Stefanini; G L Gessa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

7.  Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester.

Authors:  B Scatton; P Worms
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

8.  Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat.

Authors:  S M Wuerthele; N M Friedle; K E Moore
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

9.  Effect of low concentrations of apomorphine on parkinsonism in a randomized, placebo-controlled, crossover study.

Authors:  Steven A Gunzler; Caroline Koudelka; Nichole E Carlson; Misha Pavel; John G Nutt
Journal:  Arch Neurol       Date:  2008-02

10.  Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.

Authors:  E M Pich; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.